.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AM03_EthambutolAndIsoniazid.EthambutolAndIsoniazid .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AM03_EthambutolAndIsoniazid.EthambutolAndIsoniazid| name: | EthambutolAndIsoniazid |
| ATC code: | J04AM03 | route: | oral |
| n-compartments | 1 |
Ethambutol and isoniazid is a fixed combination antituberculosis medication used primarily for the treatment of tuberculosis. Ethambutol acts by inhibiting cell wall synthesis, while isoniazid is a prodrug that inhibits the synthesis of mycolic acids. This combination is approved and widely used as part of multi-drug regimens for the treatment of tuberculosis.
Population pharmacokinetics of ethambutol and isoniazid in adult patients with tuberculosis, administered orally as fixed-dose combination tablets.